Urology surgical instruments market seen reaching $22.66B by 2030

The urology surgical instruments market is projected to grow from $15.43 billion in 2026 to $22.66 billion by 2030, according to The Business Research Company. Rising urologic disease rates, more minimally invasive procedures and stronger demand in North America and Asia Pacific are driving the outlook.

Why it matters: - The urology surgical instruments market is tied to rising demand for diagnosis and treatment of kidney disease, urinary tract disorders, prostate conditions and urologic cancers. - Faster growth in this category points to more procedures, more frequent instrument replacement and greater use of specialized surgical tools in hospitals, clinics and dialysis centers. - The market’s expected expansion to $22.66 billion by 2030 signals continued spending on minimally invasive and precision-based urology care.

What happened: - The Business Research Company released its Urology Surgical Instruments Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The report says the global market rose from $14.14 billion in 2025 to $15.43 billion in 2026. - The report projects a 10.1% CAGR from 2026 to 2030, with the market reaching $22.66 billion. - North America held the largest market share in 2025. - Asia Pacific is expected to be the fastest-growing region during the forecast period.

The details: - The market’s recent growth has been supported by higher rates of kidney disease and urinary tract disorders. - Hospital-based urological surgeries have increased demand for rigid and flexible endoscopes used for diagnosis and treatment. - Demand for urology consumables and accessories has also helped lift the market. - Pelvic organ prolapse surgeries and benign prostatic hyperplasia, or BPH, procedures have added to market growth. - Future growth is expected to come from advanced surgical instruments designed for minimally invasive techniques. - More procedures in dialysis and specialized centers are expected to increase instrument use. - Adoption of peripheral and diagnostic urology systems is another growth driver. - Oncology-related urological interventions and ongoing instrument upgrades are expected to support higher surgical precision and efficiency. - The report highlights rising demand for ergonomically designed instruments, reusable consumables and procedure-specific tools. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report also adds market attractiveness scoring, total addressable market analysis, company scoring matrix graphics, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables. - The report defines urology surgical instruments as specialized tools for diagnosing and treating conditions affecting the male reproductive system and urinary tract.

Between the lines: - The growth outlook suggests urology suppliers may benefit most from products that improve speed, precision and workflow in minimally invasive procedures. - The strongest demand appears likely to come from settings handling chronic disease, cancer care and high procedure volumes. - Prostate cancer trends reinforce the broader need for urology instruments as patient volumes rise. - Prostate Cancer Research said in November 2024 that prostate cancer is the second leading cause of cancer-related deaths among men in the UK, after lung cancer, and that UK incidence is projected to rise 15% between 2023 and 2025.

What's next: - The market is expected to keep expanding through 2030 as procedure volumes rise and providers replace instruments more often. - Asia Pacific’s faster growth could make it a key battleground for manufacturers seeking new sales. - More demand is likely for specialized kidney disease and urological cancer tools as care shifts toward targeted procedures. - More information is available in the full report and a free sample of the report.